Long-Term Observation of Triplex Surgery for Cataract after Phakic 6H Implantation for Super High Myopia
Table 2
Clinical data before and after triplex surgery.
Case/eye
Follow-up period (m)
Pupil diameter (mm)
LOCS III classification
Phacoemulsification
BCVA (logMAR)
SE after the triplex surgery
ECD (cells/mm2)
IOL
Power
Time
Pre
Post
At last follow-up
Pre
Post (1 m)
At last follow-up
Power
Model
1/R
54
N3C1P1
12.0
18
0.40
0.40
1.00
−2.25
1889
1750
681
4.0
Rayner
1/L
54
N4C2P1
12.5
21
0.60
0.60
1.00
−0.75
1495
1153
572
3.0
Rayner
2/R
63
N3C1P1
11.3
10
0.60
1.30
1.00
−2.25
1832
1765
1015
6.0
HumanOpt
2/L
57
N1C1P1
1.0
1
1.00
1.30
3.00
−3.75
1676
1298
1224
4.0
HumanOpt
3/R
36
N3C1P1
9.0
13
0.52
0.10
0.10
−1.50
2122
2072
1987
5.0
Rayner
3/L
36
N2C1P1
2.0
2
0.70
1.00
1.00
−0.75
1314
1215
980
2.0
Rayner
4/R
36
N3C1P1
10.0
17
0.40
0.00
0.00
−1.75
2077
2105
2011
4.0
HumanOpt
4/L
26
N3C2P1
12.5
21
0.52
0.00
0.00
−2.75
2228
2205
2033
6.0
HumanOpt
5/L
38
N3C1P1
9.9
15
0.30
0.00
0.00
−2.50
1422
1399
1348
−2.0
HumanOpt
6/R
24
N3C1P1
16.6
12
0.52
0.22
0.15
−0.50
1869
1843
1889
−1.0
HumanOpt
6/L
51
N3C1P1
12.5
13
0.52
0.22
0.22
−1.75
2028
2023
1988
−2.0
HumanOpt
7/R
67
N4C2P1
21.0
30
1.40
1.00
0.82
−0.50
2238
2249
2591
−5.0
MA60MA
8/R
54
N2C1P1
11.5
9
0.70
0.30
0.30
−1.75
2274
2324
2363
−3.5
MA60MA
8/L
55
N3C1P1
17.0
20
0.52
0.22
0.30
−1.50
2419
2342
2465
−3.0
MA60MA
9/L
59
N2C1P1
8.0
11
1.30
0.70
0.60
−1.25
3255
3181
2813
−6.0
HumanOpt
10/L
29
N3C1P1
13.0
14
0.60
0.15
0.15
−0.25
1660
1559
1647
2.0
HumanOpt
Mean (SD)
46 (14)
11.1 (6.5)
15.8 (9.2)
0.66 (0.31)
0.47 (0.46)
0.60 (0.75)
−1.61 (0.95)
1987 (468)
1905 (524)
1725 (688)
0.8 (4.0)
m: month(s); BCVA: best corrected visual acuity; Pre: before the triplex surgery; Post: after the triplex surgery; ECD: endothelial cell density; SE: spherical equivalent.
